Cardiovascular disease: identifying and supporting people most at risk of dying early
KEYWORDS: health, evidence, services, disadvantaged, people, interventions, smoking, studies, study, risk, cessation, local, review, effectiveness, smoking cessation

authority directors, primary care trust directors of public health and public health teams, commissioning managers and performance managers, GPs and primary care nurses. They also included community pharmacists, health trainers and managers and representatives from other public and voluntary organisations, including New Deal for Communities. The fieldwork comprised: A qualitative study involving a range of different professionals across 4 locations (Coventry, Liverpool, London and Northampton) carried out by Dr Foster Intelligence. The main issues arising from this study are set out in appendix C under fieldwork findings. See the full fieldwork report 'Reducing the rate of premature deaths from CVD and other smoking-related diseases: finding and supporting those most at risk and improving access to services'. How PHIAC formulated the recommendations At its meetings in November 2007 and March 2008 PHIAC considered the evidence of effectiveness and cost effectiveness to determine: • whether there was sufficient evidence (in terms of quantity, quality and applicability) to form a judgement • whether, on balance, the evidence demonstrates that the intervention is effective or ineffective, or whether it is equivocal • where there is an effect, the typical size of effect. PHIAC developed draft recommendations through informal consensus, based on the following criteria.
